Tag Archives: drug development

Take the PKD Foundation Challenge

Jill Panetta

By Jill Panetta, Chief Scientific Officer, PKD Foundation Polycystic Kidney Disease (PKD) Awareness Week has been designated the week of June 18 to 24, 2012.  This week allows the PKD Foundation to be able to fulfill part of its mission to people with PKD — to increase awareness of a disease which few know about and raise the understanding and the impact that PKD has on patients and their families. Autosomal dominant polycystic kidney disease Read More >

Health  |  4 Comments  |  Email This Post
Tags: , , ,

Fox Trial Finder and You: Use It to Recruit for Your Trials or to Get Involved Yourself!


From The Michael J. Fox Foundation for Parkinson’s Research The Michael J. Fox Foundation has launched Fox Trial Finder, a new Web tool that uses state-of-the art technology to connect potential study volunteers with the coordinators of clinical studies that need someone with their specific medical history. The goal is to benefit both study sponsors and patients by getting people into clinical trials and studies faster — speeding the development of new treatments and ultimately a Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , ,

International Rare Disease Day: Join the Movement

Nicole Boice

By Nicole Boice, President and Founder, RARE Project Being diagnosed with any illness can be overwhelming. Imagine what it’s like, though, to be diagnosed with a disease that you’ve never heard of – maybe even one that your doctor has never seen before. Millions of people start this diagnostic odyssey on their own, with little or no support, no real direction, with feelings of isolation and fear. That’s exactly the situation in which millions of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

“Alz” Well That Ends Well: The Beta-Amyloid Debate in Alzheimer’s Research


Researchers and clinicians alike believe there is substantial evidence to support the hypothesis that Alzheimer’s disease (AD) may be caused by deposition of amyloid beta-peptide (Abeta) in plaques in brain tissue. But drugs targeted towards the beta-amyloid have met with significant setbacks challenging whether the target is, in fact, real. With several late stage drugs targeting beta-amyloid poised for market entry, a panel of opinion leaders in the treatment of Alzheimer’s and scientific industry specialists Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Real Reason Why Salk Refused to Patent the Polio Vaccine


Editor’s Note: Despite the progress in polio and other diseases made possible by vaccines, today we are witnessing a resurgence of vaccine-preventable illnesses as nervous parents skip their children’s shots. Watch the PBS documentary Vaccines—Calling the Shots to find learn more.  BIO is also a leading voice on the patent-ability of biotech inventions and other IP matters. To get the most recent updates on IP in the biotech world, please sign up for BIO’s free bi-monthly IP Newsletter. Read More >

Patently BIOtech  |  24 Comments  |  Email This Post
Tags: , , , , , , ,